BACKGROUND:Fortetropin is a proteo-lipid complex made from fertilized egg yolk and, in young men, has been shown to increase lean body mass. METHODS: The purpose of this study was to examine the effects of 21 days of Fortetropin supplementation on the fractional synthetic rate (FSR) of muscle protein in 10 healthy, older men and 10 women (66.4 ± 4.5 y). We used 2H2O labeling to measure FSR of multiple muscle protein ontologies. D3-creatine dilution was used to determine muscle mass at baseline. Subjects ingested 70% 2H2O for 21 day and saliva samples were collected to determine body 2H2O enrichment. A microbiopsy was obtained from the m. vastus lateralis on Day 21. Subjects were randomly assigned to Fortetropin (19.8 g/d) or placebo (cheese powder, 19.8 g/d). RESULTS: Restricting kinetic data to proteins with ≥2 peptides measured in at least 4 subjects per group resulted in 117 proteins meeting these criteria. The mean FSR for a majority of proteins in several muscle gene ontologies was higher in the Fortetropin group compared to placebo (32/38 myofibril proteins, 33/44 sarcoplasmic proteins, and 12/17 mitochondrial proteins) and this proportion was significantly different between groups using a binomial test and were independent of sex or baseline muscle mass. CONCLUSIONS: The overall magnitude of the difference in muscle protein FSR of Fortetropin from placebo was 18%, with multiple gene ontologies affected. While these results should be confirmed in larger cohorts, they suggest that Fortetropin supplementation is effective for promoting muscle protein synthesis in older people.
RCT Entities:
BACKGROUND:Fortetropin is a proteo-lipid complex made from fertilized egg yolk and, in young men, has been shown to increase lean body mass. METHODS: The purpose of this study was to examine the effects of 21 days of Fortetropin supplementation on the fractional synthetic rate (FSR) of muscle protein in 10 healthy, older men and 10 women (66.4 ± 4.5 y). We used 2H2O labeling to measure FSR of multiple muscle protein ontologies. D3-creatine dilution was used to determine muscle mass at baseline. Subjects ingested 70% 2H2O for 21 day and saliva samples were collected to determine body 2H2O enrichment. A microbiopsy was obtained from the m. vastus lateralis on Day 21. Subjects were randomly assigned to Fortetropin (19.8 g/d) or placebo (cheese powder, 19.8 g/d). RESULTS: Restricting kinetic data to proteins with ≥2 peptides measured in at least 4 subjects per group resulted in 117 proteins meeting these criteria. The mean FSR for a majority of proteins in several muscle gene ontologies was higher in the Fortetropin group compared to placebo (32/38 myofibril proteins, 33/44 sarcoplasmic proteins, and 12/17 mitochondrial proteins) and this proportion was significantly different between groups using a binomial test and were independent of sex or baseline muscle mass. CONCLUSIONS: The overall magnitude of the difference in muscle protein FSR of Fortetropin from placebo was 18%, with multiple gene ontologies affected. While these results should be confirmed in larger cohorts, they suggest that Fortetropin supplementation is effective for promoting muscle protein synthesis in older people.
Authors: Peggy M Cawthon; Terri Blackwell; Steven R Cummings; Eric S Orwoll; Kate A Duchowny; Deborah M Kado; Katie L Stone; Kristine E Ensrud; Jane A Cauley; William J Evans Journal: J Gerontol A Biol Sci Med Sci Date: 2021-01-01 Impact factor: 6.053
Authors: Mahalakshmi Shankaran; Todd W Shearer; Stephen A Stimpson; Scott M Turner; Chelsea King; Po-Yin Anne Wong; Ying Shen; Philip S Turnbull; Fritz Kramer; Lisa Clifton; Alan Russell; Marc K Hellerstein; William J Evans Journal: Am J Physiol Endocrinol Metab Date: 2015-12-29 Impact factor: 4.310
Authors: Marissa J Schafer; Elizabeth J Atkinson; Patrick M Vanderboom; Brian Kotajarvi; Thomas A White; Matthew M Moore; Charles J Bruce; Kevin L Greason; Rakesh M Suri; Sundeep Khosla; Jordan D Miller; H Robert Bergen; Nathan K LeBrasseur Journal: Cell Metab Date: 2016-06-14 Impact factor: 27.287
Authors: Denise K Houston; Barbara J Nicklas; Jingzhong Ding; Tamara B Harris; Frances A Tylavsky; Anne B Newman; Jung Sun Lee; Nadine R Sahyoun; Marjolein Visser; Stephen B Kritchevsky Journal: Am J Clin Nutr Date: 2008-01 Impact factor: 7.045
Authors: Peggy M Cawthon; Eric S Orwoll; Katherine E Peters; Kristine E Ensrud; Jane A Cauley; Deborah M Kado; Marcia L Stefanick; James M Shikany; Elsa S Strotmeyer; Nancy W Glynn; Paolo Caserotti; Mahalakshmi Shankaran; Marc Hellerstein; Steven R Cummings; William J Evans Journal: J Gerontol A Biol Sci Med Sci Date: 2019-05-16 Impact factor: 6.053